CLLS
Cellectis S.A. - American Depositary Shares (CLLS)
$17
About Cellectis S.A. - American Depositary Shares (CLLS)
Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquartered in Paris, France.
Details
Daily high
$1.25
Daily low
$1.12
Price at open
--
52 Week High
$5.45
52 Week Low
$0.88
Market cap
78.8M
Dividend yield
-
Volume
21
Avg. volume
104,916
P/E ratio
-1.68
Cellectis S.A. - American Depositary Shares News
Details
Daily high
$1.25
Daily low
$1.12
Price at open
--
52 Week High
$5.45
52 Week Low
$0.88
Market cap
78.8M
Dividend yield
-
Volume
21
Avg. volume
104,916
P/E ratio
-1.68